Notícias Fortress Biotech Inc - FBIO | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Fortress Biotech Inc (FBIO)
Fortress Biotech Inc (FBIO) Notícias

Fortress Biotech Inc (FBIO)

1,57

-0,02

(-1,26%)

Fechado 20 Novembro 6:00PM

Atrasado por 15 minutos

1,5898

0,0198

( 1,26% )

Pré-mercado: 10:22AM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Avenue Therapeutics to Participate in Upcoming Investor Conferences

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024

Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

Fortress Biotech Announces Pause in Payment of Dividends on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy

Avenue Therapeutics Announces Last Patient Last Visit in Phase 1b/2a Clinical Trial of AJ201 for the Treatment of Spinal and Bulbar Muscular Atrophy (Kennedy's Disease)

Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

Fortress Biotech Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

1
2
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Fortress Biotech

Johnson Matthey

Rogers Communications

Allianz Technology

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições